P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE

• Yasunori Kogure,
• Hiroshi Handa,
• Yuta Ito,
• Masaki Ri,
• Yuichi Horigome,
• Masaki Iino,
• Yoriko Harazaki,
• Takahiro Kobayashi,
• Masahiro Abe,
• Tadao Ishida,
• Shigeki Ito,
• Hiromi Iwasaki,
• Junya Kuroda,
• Hirohiko Shibayama,
• Kazutaka Sunami,
• Hiroyuki Takamatsu,
• Hideto Tamura,
• Toshiaki Hayashi,
• Kiwamu Akagi,
• Tomohiro Shinozaki,
• Takahiro Yoshida,
• Ikuo Mori,
• Shinsuke Iida,
• Takahiro Maeda,
• Keisuke Kataoka

Affiliations

Yasunori Kogure

1 National Cancer Center Research Institute, Division of Molecular Oncology, Tokyo, Japan

Hiroshi Handa

2 Gunma University Graduate School of Medicine, Department of Hematology, Maebashi, Japan

Yuta Ito

1 National Cancer Center Research Institute, Division of Molecular Oncology, Tokyo, Japan

Masaki Ri

4 Nagoya City University Graduate School of Medical Sciences, Department of Hematology and Oncology, Nagoya, Japan

Yuichi Horigome

5 Kitasato University School of Medicine, Department of Hematology, Sagamihara, Japan

Masaki Iino

6 Yamanashi Prefectural Central Hospital, Department of Hematology, Kofu, Japan

Yoriko Harazaki

7 Miyagi Cancer Center, Department of Hematology, Natori, Japan

Takahiro Kobayashi

8 Akita University Graduate School of Medicine, School of Medicine, Department of Hematology, Nephrology and Rheumatology, Akita, Japan

Masahiro Abe

9 Tokushima University Graduate School, Department of Hematology, Endocrinology and Metabolism, Tokushima, Japan

Tadao Ishida

10 Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan

Shigeki Ito

11 Iwate Medical University Hospital, Department of Hematology and Oncology, Yahaba, Japan

Hiromi Iwasaki

12 National Hospital Organization Kyushu Medical Center, Department of Hematology, Fukuoka, Japan

Junya Kuroda

13 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Kyoto, Japan

Hirohiko Shibayama

14 National Hospital Organization Osaka National Hospital, Department of Hematology, Osaka, Japan

Kazutaka Sunami

15 National Hospital Organization Okayama Medical Center, Okayama, Japan

Hiroyuki Takamatsu

16 Kanazawa University Hospital, Department of Hematology, Kanazawa, Japan

Hideto Tamura

17 Nippon Medical School, Department of Hematology, Tokyo, Japan

Toshiaki Hayashi

18 Teine Keijinkai Hospital, Department of Hematology, Sapporo, Japan

Kiwamu Akagi

19 Saitama Cancer Center, Division of Molecular Diagnosis and Cancer Prevention, Ina, Japan

Tomohiro Shinozaki

20 Tokyo University of Science, Department of Information and Computer Technology, Faculty of Engineering, Tokyo, Japan

Takahiro Yoshida

21 Takeda Pharmaceutical Company Limited, Tokyo, Japan

Ikuo Mori

21 Takeda Pharmaceutical Company Limited, Tokyo, Japan

Shinsuke Iida

4 Nagoya City University Graduate School of Medical Sciences, Department of Hematology and Oncology, Nagoya, Japan

Takahiro Maeda

22 Kyushu University Graduate School of Medical Sciences, Division of Precision Medicine, Fukuoka, Japan

Keisuke Kataoka

1 National Cancer Center Research Institute, Division of Molecular Oncology, Tokyo, Japan